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Background: Gender-related differences in humans are commonly observed in behaviour, physical activity, disease,
and lifespan. However, the notion that age-related changes in the immune system differ between men and women
remains controversial. To elucidate the relationship between immunological changes and lifespan, peripheral blood
mononuclear cells from healthy Japanese subjects (age range: 20–90 years; N = 356) were analysed by using
three-colour flow cytometry. The proliferative activities and cytokine-producing capacities of T cells in response to
anti-CD3 monoclonal antibody stimulation were also assessed.
Results: An age-related decline in the number of T cells, certain subpopulations of T cells (including CD8+ T cells,
CD4+CDRA+ T cells, and CD8+CD28+ T cells), and B cells, and in the proliferative capacity of T cells was noted. The
rate of decline in these immunological parameters, except for the number of CD8+ T cells, was greater in men than
in women (p < 0.05). We observed an age-related increase or increasing trend in the number of CD4+ T cells, CD4+
CDRO+ T cells, and natural killer (CD56+CD16+) cells, as well as in the CD4+ T cell/CD8+ T cell ratio. The rate of
increase of these immunological parameters was greater in women than in men (p < 0.05). T cell proliferation
index (TCPI) was calculated from the T cell proliferative activity and the number of T cells; it showed an age-related
decline that was greater in men than in women (p < 0.05). T cell immune score, which was calculated using 5 T cell
parameters, also showed an age-related decline that was greater in men than in women (p < 0.05). Moreover, a trend
of age-related decreases was observed in IFNγ, IL-2, IL-6, and IL-10 production, when lymphocytes were cultured
with anti-CD3 monoclonal antibody stimulation. The rate of decline in IL-6 and IL-10 production was greater in
men than in women (p < 0.05).
Conclusion: Age-related changes in various immunological parameters differ between men and women. Our
findings indicate that the slower rate of decline in these immunological parameters in women than that in men is
consistent with the fact that women live longer than do men.
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Immunological functions are known to decline with age
in animal models and humans [1-3]. An understanding
of immunological functions at an individual level is
clinically important because immunological decline is* Correspondence: hirokawa.pth2@tmd.ac.jp
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reproduction in any medium, provided the oraccompanied by various ailments such as infections,
cancer, vascular diseases, and possibly autoimmune
phenomena in the aged.
The concept of immunosenescence reflects changes
in both cellular and humoral immune responses. Ac-
cumulating evidence obtained mainly from animal
models has shown that age-related immunological de-
cline occurs primarily in T cell-dependent immune
functions, and it is mainly caused by thymic involution
that begins in the early phase of life [3]. As a result, T
cells are central to the immune response, and their
function is significantly altered with increasing age. Inal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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obtained from blood serum and blood cells. Serum
contains immunoglobulin, complements, and cytokines.
The levels of serum IgG and IgA generally tend to increase
slightly with age [4], while the level of serum complements
does not change remarkably with age. The level of cyto-
kines in healthy old people is generally reduced. In contrast,
the level of white blood cells (WBCs) remarkably changes
with disease and aging. WBCs are constituted of lympho-
cytes, monocytes, and neutrophils. There are various sub-
populations of lymphocytes with different functions. Data
on age-related changes in human lymphocytes and their
functions are limited.
Besides aging, the fact that gender influences the immune
system has long been recognised. In postmenopausal
women, changes in the immune system have been attrib-
uted to oestrogen deprivation. Women are at higher risk
for developing autoimmune diseases, which suggests that
these diseases are somehow mediated by sex steroids, with
oestrogens as enhancers, at least with humoral immunity.
There is an increase in proinflammatory serum markers,
an increasing response of the body’s cells to cytokines,
a decrease in CD4+ T and B lymphocytes, and in the
cytotoxic activity of natural killer (NK) cells [5]. One
cellular process related to lifespan, which differs
according to sex, is the rate at which the protective
telomere chromosome caps are lost. In humans, men
have shorter lifespans and greater telomere shortening
than do women. This has led to speculation in the
medical literature that sex-specific telomere shortening is
one cause of sex-specific mortality [6].
Therefore, the purpose of this study is to obtain data
on age-related changes and gender differences in the
number and function of peripheral blood lymphocytes
and their subpopulations obtained from 162 healthy
male and 194 healthy female volunteers, ranging in age
from 20 to 90 years. The results show that the rate of
age-related immunological decline is less in women than
in men, and this could be a contributory factor to
women living longer than men in Japan.
Results
1) Age-related changes in RBCs and WBCs (Table 1)Table 1 Age-related change of RBC and WBC in male and femal
Hematological
parameters
Men (N = 162)
Slope Intercept R p-value Slo
RBC※ −0.033 6.37 0.517 0.001 −0.0
WBC※ −0.099 11.27 0.138 0.082 −0.0
Lymphocytes※ −43.30 4455 0.148 0.059 33.
Neutrophils※ −71.31 7087 0.095 0.218 −73
※:Number / mm3. R: Correlation coefficient. NS: not significant.A significant age-related decrease in the number of
RBCs was observed in men (p < 0.001) but not in
women (Table 1), although absolute levels of RBCs
in subjects over 60 years was significantly higher in
men than in women (Table 2). The age-related
difference in the number of RBCs between men and
women was statistically significant (p < 0.001).
The number of neutrophils showed a decreasing
trend with age in both men (slope: -71.31, p = 0.218)
and women (slope: -70.39, p = 0.009), but no
significant difference was observed (Table 1).
The number of lymphocytes showed a decreasing
trend with age in men (slope: -43.30, p = 0.059) and
an increasing trend with age in women (slope: 33.05,
p = 0.996), and the difference between genders was
statistically significant (p = 0.016, Table 1). Therefore,
the number of lymphocytes was higher in young
men than in young women (data, not shown), but
the absolute number of T cells in people over 60
years was almost the same between men and women
(Table 2).
2) Immunological parameters showing age-related
decline (Table 3)(a) T cells.
The number of T cells (CD3+) decreased
significantly with age in men (slope: -33.00, p = 0.018),
and had a decreasing trend with age in women
(slope: -26.57, p = 0.212). The rate of decline with
age was greater in men than in women (p = 0.049,
Figure 1a and b, Table 3).
(b) CD8+T cells.
A subpopulation of CD8+ T cells showed an
age-related decrease in both men (slope: -15.49,
p < 0.001) and women (slope: -13.24, p < 0.001),
while the magnitude of the decrease between
them was not statistically significant
(Figure 1c and d, Table 3).
(c) CD8+CD28+ T cells.
A subpopulation of CD8+CD28+ T cells showed an
age-related decrease in both men (slope: -11.21,
p < 0.001) and women (slope: -8.664, p < 0.001,
Fig. 1e and f), and the rate of this decline was
greater in men than in women (p < 0.04, Table 3).
(d) Naïve T cells.e subjects
Women (N = 194) Gender difference
pe Intercept R P-value p-value
21 5.238 0.105 0.138 0.001
91 9.980 0.155 0.033 NS
05 452 <0.001 0.996 0.016
.39 6202 0.187 0.009 NS
Table 2 Gender difference in people over 60 years old
Immunological parameters Men Women
N = 54 N = 48
T cells (number/mm3) 1365 ± 53 1395 ± 73
CD4+ T cells (number/mm3) 910 ± 59 961 ± 55
T cell proliferation index 1.72 ± 0.11 1.87 ± 0.12
T cell immune score 11.6 ± 0.3 11.7 ± 0.3
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cells) showed a decreasing trend with age in both
men (slope: -15.39, p = 0.261) and women
(slope: -10.88, p = 0.447, Table 3), which was greater
in men than women; the difference between them
was statistically significant (p = 0.001).
(e) T cell proliferative activity.
A proliferative response of T cells to anti-CD3
monoclonal antibody stimulation was measured by
the MTS method and was expressed as OD490
(MTS-OD490). The results showed an age-related
decrease in both men (slope: -0.019, p < 0.001) and
women (slope: -0.016, p = 0.002, Table 3), but no
gender difference was observed.
(f ) T cell proliferation index (TCPI).
TCPI showed an age-related decrease in both men
(slope: -0.056, p < 0.001) and women (slope: -0.043,
p = 0.008, Fig. 1g and h). The decrease was greater
in men (slope: -0.056) than in women
(p = 0.01, Table 3).
(g) T cell immune score.
The T cell immune score was calculated by using 5
parameters as described in the Methods. The T cell
immune score showed an age-related decrease in
both men (slope: -0.137, p = 0.001) and women
(slope: -0.107, p < 0.001, Table 3). A greater decrease
was observed in men than women (p = 0.006).
(h) B cells.ble 3 Immunological parameters showing an age-related dec
munological parameters Male (N = 162)
Slope Intercept R p-value
) T cells※ −33.00 3196 0.187 0.018
) CD8 + T cells※ −15.94 1315 0.286 <0.001
) CD8 + CD28+ T cells※ −11.21 863 0.543 <0.001
) Naïve T cells※ −15.39 1205 0.089 0.261
) T cells proliferative activity −0.019 2.295 0.315 <0.001
T cell proliferation index −0.056 4.904 0.290 <0.001
) T cell immune score −0.137 19.3 0.261 0.001
) B cells※ −11.04 747 0.167 0.034
: Number / mm3. R: Correlation coefficient. NS: not significant.The number of B cells (i.e. CD20+ lymphocytes)
showed a decrease with age in men (slope: -11.04,
p = 0.034) and showed a decreasing trend with age
in women (slope: -4.307, p = 0.152); the magnitude
of the decrease between men and women was
statistically significant (p = 0.001, Table 3).
3) Immunological parameters showing age-related
increases (Table 4)








−A subpopulation of CD4+ T cells was maintained
at steady state in men (slope:23.28, p=0.9897) and
showed an increasing trend with age in women
(slope: 16.92, p=0l075). The slope was greater in
men than in women, and the difference between
them was statistically significant (p = 0.005,
Table 4).
(b) The ratio of CD4+ T cells to CD8+ T cells
(CD4/CD8 ratio).
The CD4/CD8 ratio increased with age in both
men (slope: 0.087, p < 0.001) and women
(slope: 0.064, p < 0.001), and this increase was
significantly greater in men than women
(p = 0.001, Fig. 2g and 2h, Table 4).
(c) Memory T cells.
The number of memory T cells (CD4+CD45RO+)
showed an increasing trend with age in men
(slope: 12.35, p = 0.153), and a significant age-related
increase in women (slope: 10.11, p < 0.001); the
magnitude of increase was significantly greater in
men than in women (p < 0.001, Table 4).
(d) CD4+CD25+ T cells.
A subpopulation of CD4+CD25+ T cells showed an
increasing trend with age in both men (slope: 1.83,
p = 0.379) and women (slope: 1.602, p = 0.233),
but no gender difference was observed (Table 4).
(e) NK cells.
The number of NK cells (CD56+CD16+) showed
an age-related increase in women (slope: 11.94,
p < 0.001) and an increasing trend with age inFemale (N = 194) Gender difference
Slope Intercept R p-value p-value
26.57 2628 0.089 0.212 0.049
13.24 1075 0.305 <0.001 NS
8.664 696 0.477 <0.001 0.04
10.88 916 0.055 0.447 0.001
0.016 2.115 0.224 0.002 NS
0.043 3.910 0.190 0.008 0.010
0.106 17.3 0.333 <0.001 0.006
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Figure 1 Age-related change in the number of T cells, CD8+ T cells, CD8+CD28+ T cells and TCPI in men and women. The slopes of
T cells are -33.00 (a: men) versus -26.57 (b: women). The slopes of CD8+ T cells are -15.94 (c: men) versus -13.24 (d: women). The slopes of
CD8+CD28+ T cells are -11.21 (e: men) versus -8.66 (f: women). The slopes of TCPI are -0.056 (g: men) versus -0.043 (h: women). Gender difference
is observed in T cells (p = 0.049), CD8+CD28+ T cells (p = 0.04) and TCPI (p = 0.01).
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Table 4 Immunological parameters showing an age-related increase
Immunological
parameters
Male (N = 162) Female (N = 194) Gender difference
Slope Intercept R p-value Slope Intercept R p-value p-value
(a) CD4 + T cells※ 23.28 −313 <0.001 0.990 16.92 77 0.114 0.107 0.004
(b) CD4/CD8 ratio 0.087 −2.260 0.316 <0.001 0.064 −0.713 0.452 <0.001 0.001
(c) Memory T cells※ 12.35 −141 0.114 0.153 10.11 −91 0.253 <0.001 <0.001
(d) CD4 + CD25 + T cells ※ 1.830 −47 0.077 0.379 1.602 −33 0.100 0.233 NS
(e) NK cells※ 17.41 −449 0.105 0.194 11.94 −186 0.268 <0.001 0.001
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the increase was significantly greater in men than
in women (p < 0.001, Table 4).4) Cytokine production (Table 5)
The production of IFNγ, IL-2, IL-6, and IL-10
showed a decreasing trend with age, although the
results were not statistically significant, with the
exception of IL-6 in men (Table 5). However,
SAM analysis revealed that there was a significant
difference in IL-6 and IL-10 between men and
women. The slope of IL-6 was greater in women
(-488.0) than in men (-293.0), and the slope of IL-10
was greater in men (-51.4) than in women (-28.1).
Discussion
The age-related decline of the immune response has a
major impact on the health status of the elderly [7] and
is a determinant of longevity [8]. It is well known that
aging is associated with a decline in the normal function
of the immune system, leading to increased susceptibility
to various diseases and shortened longevity; however,
specific dysfunctions in the immune system directly
responsible for this have yet to be identified. Among
the important factors, T cells are central to the immune
response, and their function is significantly altered with
increasing age. The present study confirms and extends
an earlier study by Utsuyama et al. [1].
Previously, Strindhall et al. [9] reported that a reduced
number of CD8+CD28- T cells and a higher CD4+ T cell/
CD8+ T cell ratio are associated with populations that
survive until the age of 100 years. Moreover, Xie and
McElhaney [10] reported that susceptibility to influenza
infection in older adults is associated with an increase inCytokine production and age in male and female sub
logical
ers
Men (N = 64)
Slope Intercept R p-value
−45.2 4698 0.721 0.071
−19.2 1129 0.138 0.319
−293.0 18732 0.247 0.048
−51.6 3407 0.176 0.166
ion coefficient. NS: not significant.the number of CD8+CD28- T cells. In this study, we
found that the number of CD8+CD28+ cells decreased
with age, and this was associated with a decrease in the
T cell proliferative response (MTS-OD490) and TCPI.
Furthermore, the rate of decline was significantly less in
women than in men.
Although CD4+CD25+ regulatory T cells are crucial to
tolerance in normal individuals, the factors regulating
this cell population and its function are largely unknown.
In the present study, we demonstrated that the number of
CD4+CD25high regulatory T cells (TREGs) showed an
increasing trend with age. Further studies are required
because it is still not clear whether the age-related increase
in the number of TREGs is responsible for immune
dysfunction in the elderly [11].
Olsson et al. (2000) reported that a decrease in the
CD4+ T cell/CD8+ T cell ratio was an important indicator
of the immune risk phenotype. In the present survey, a
contrasting feature was observed between CD4+T cells
and CD8+T cells. The results presented here show that the
number of CD4+ T cells was maintained at a relatively
steady level or had an increasing trend with age, whereas
the number of CD8+ T cells significantly decreased with
age; therefore, the CD4+ T cell/CD8+ T cell ratio showed a
distinct age-related increase. A higher percentage of CD8+
T cells and a decreased CD4+ T cell/CD8+ T cell ratio were
observed in the Saudi male population than that in the
Caucasian population [12]. Hence, it is possible that race
is a factor influencing these parameters.
T cell proliferative activity is a value obtained by a
determined number of T cells in vitro, and it does not
directly reflect a value at the individual level. In order
to convert the T cell proliferative activity to the individualjects: regression analysis
Women (N = 49) Gender difference
Slope Intercept R p-value p-value
−48.1 4677 0.122 0.397 NS
−17.2 928 0.243 0.108 NS
−488.0 29289 0.077 0.605 0.010
−28.1 1898 0.063 0.666 0.004
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calculated by the T cell proliferative activity and the
number of T cells/mm3. Both T cell proliferative activ-
ity and TCPI showed age-related decreases in men and
women. However, statistically significant differences
between men and women were observed in TCPI, not
in T cell proliferative activity.
In addition, we developed another novel immunological
parameter, T cell immune score, which was calculated by
combining 5 T cell-related parameters: number of T cells,
CD4/CD8 T cell ratio, number of naïve T cells, naïve to
memory T cell ratio, and TCPI. Each parameter was given a
score from 3 to 1 according to the database: 3 (high level),
2 (moderate level), and 1 (low level). The summation of 5
scores was employed as the T cell immune score. It is
interesting to note that the T cell immune score signifi-
cantly decreased with age in both men and women, and the
decline was significantly greater in men than in women.
The absolute number of total B lymphocytes increases
about 3-fold from the baseline in the first year of life and
progressively decreases until adulthood [13]. The present
study showed that the number of B cells decreased grad-
ually throughout life from 20 to 90 years of age, and this
decline was significantly greater in men than in women.
NK cells are a key component of innate immunity and
are involved in the regulation of the immune response
by producing many cytokines that can activate other
cellular components of innate and adaptive immunity.
Although many studies have investigated the effects of
age on NK cells, their conclusions remain controversial
[14]. In the present study, an age-related increase was
observed in the number of NK cells, and this increase
was significantly higher in men than in women. It is
interesting to note that Lee et al. [15] reported a higher
percentage of NK cells in the Asian populations than
that in the Caucasian population.
Although aging is accompanied by a progressive increase
in proinflammatory cytokines, little is known about the
development of age-dependent modifications in circulating
cytokines. The serum levels of cytokines are usually too low
to detect. Thus, in the present study, we measured the
concentration of cytokines secreted into the culture
supernatant by T cells in the presence of anti-CD3
monoclonal antibody. Many reports [16-18] employed
the stimulation of lymphocytes by PMA and ionomycin
to monitor cytokine production. Because stimulation by
the anti-CD3 monoclonal antibody is more routinely
used than PMA and ionomycin, we employed the former
method. It is known that a shift from Type 1 to Type 2
cytokine production occurs with age; however, we could
not detect such a shift. Garner and Murasko [19] reviewed
over 60 studies and reported that the age-associated
changes in cytokine production are inconsistent. We
observed that both Th-1 type cytokines (IL-2 and IFNγ)and Th-2 type cytokines (IL-6) showed an age-related
declining trend. A statistically significant decline was
observed only in IL-6 in men. The rate of age-related
decline in IL-10 was lesser in women than in men.
Because IL-10 is known to act as an immune suppressor,
a relatively lesser level of IL-10 in women could be
consistent with the fact that the age-related decline of
various immunological parameters is less pronounced
in women than in men.
Sex hormones influence both humoral and cell-mediated
immune responses, and oestrogen is one of the potential
factors in this immunological dimorphism [20]. These envi-
ronments are established by the cytokines that are released
by immune cells, particularly T helper (Th) lymphocytes. In
this regard, Pietschmann et al. [16] reported that the pattern
of cytokine production is gender specific. It is possible that
oestrogen deficiency after menopause induces a disturbance
of peripheral tolerance through CD8+ T cells bearing the
suppressor phenotype. In contrast, it was shown that
mitochondrial oxidative stress is higher in men than in
women and that the higher levels of oestrogens in
women protects them against aging by upregulating
the expression of antioxidants and longevity-related
genes [21]. It was also demonstrated that oestrogens
upregulate the expression of antioxidant enzymes via
the oestrogen receptor and MAPK activation, which in
turn activate the NF-kB signalling pathway, resulting in
the upregulation of longevity-related gene expression [21].
The role of gender in the regulation of longevity may be
linked to gender specific genetic differences, including the
expression of sex hormone patterns and the changes in
these patterns during an individual’s lifetime.
In humans, cytomegalovirus (CMV) infection has an
enormous impact on biomarkers associated with aging
of the immune system [22]. In Japan, an extensive survey
of blood serum by enzyme immunoassays revealed that the
percentage of CMV antibody positivity is approximately
87.2% in the whole population, showing an age-related
increase. However, gender difference was not observed
with regard to CMV antibody positivity and titre in each
age group [23].
The essential function of T cells is the recognition of
antigens and the following proliferative response. The
present study confirmed that a statistically significant
age-related decline was observed in T cell proliferative
activity and TCPI. TCPI was the value of individual
levels calculated from T cell proliferative activity, and it
showed a statistically significant gender difference that
was greater decline in men than in women. The lesser
rate of decline in TCPI indicates that the immunological
functions were relatively well preserved in elderly women
than in elderly men; this finding may be consistent with
the fact that women live longer than do men. As a refer-
ence, the mean lifespan of the Japanese population
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Welfare is 85.5 years in women and 79.0 years in men [24].
This approximately 6 year difference in the mean lifespan
may raise the question: Is this difference due to the
different biological ages of the men and women? To
answer the question, we compared an immunological
parameter, T cell immune score, between groups of
men 6 years younger than women. In other words, by
removing men over 70 years and women younger than
33 years, the mean age of men was 48.2 years and that of
women was 54.7 years. Then, we analysed the parameter
by comparing groups of men 6 years younger than women.
A significant difference was observed when comparing the
original male and female groups (p < 0.012); the p-value
was 0.157 when comparing groups between men 6 years
younger than women. This result obtained by rearranging
the groups suggested that the different life expectancy
between men and women could be due to differences in
biological age, and immunological parameters could be
used as a marker of the biological age.Methods
Blood specimens
Two millilitres of blood was collected in a tube containing
ethylenediaminetetraacetic acid (EDTA-2K) for haemato-
logical analysis performed using a PENTRA80 analyser
(Horiba, Kyoto, Japan). Eight millilitres of blood was
collected in a cell preparation tube (vacutainer, 362761;
Becton Dickinson [BD], NJ) for collecting mononuclear
cells for immunological analyses.Subjects
A critical issue in our understanding of human aging
and gender differences related to the immune system relies
on the health status of a wide population range. Healthy
male and female volunteers were critically selected on the
basis of clinical records and laboratory examinations. A
substantial number of individuals with various health
problems were excluded. None of the blood donors
suffered from neoplastic or autoimmune diseases; fur-
thermore, none were receiving any medications that
could influence the immune function. Routine laboratory
examinations of the serum of these individuals were
performed to examine the liver and kidney functions. A
total of 162 men and 194 women, ranging in age from 20
to 90 years, were examined. Table 6 shows the number of
male and female subjects and their ages.Table 6 Number of male and female subjects
Age (years) 20 - 29 30 - 39 40 - 49
Men 13 23 35
Female 44 32 36Ethical approval
This study was conducted in compliance with the
Declaration of Helsinki and applicable national laws
and regulations, and it was approved as no. 320 by
the Ethics Committee of Tokyo Medical and Dental
University. Written informed consent was obtained from
all subjects.
Flow cytometry
Mononuclear cells were stained with a combination of 2
or 3 monoclonal antibodies (mAbs) conjugated with 2 or
3 chromophores. A fluorescence-activated cell sorting flow
cytometer (FACScan BD) was employed.
Monoclonal antibodies (mABs)
The following mABs were used: fluorescein isothiocyanate
(FITC) conjugated anti-CD4, FITC-conjugated anti-CD20,
and FITC-conjugated anti-CD16; phycoerythrin (RD1)
conjugated anti-CD3, RD1-conjugated anti-CD8, and
RD1-conjugated anti-CD25; phycoerythrin-Texas Red
(ECD)-conjugated anti-CD45RA and ECD-conjugated
anti-CD3; phycoerythrin-cyanin 5.1 (PC5)-conjugated
anti-CD28; and phycoerythrin (PE)-conjugated anti-CD56.
Those mAbs were purchased from Beckman Coulter
(Miami, FL). The following combinations of mAbs
were used: CD3-RD1/CD20-FITC, CD4-FITC/CD8-RD1/
CD45RA-ECD, CD4-FITC/CD8-RD1/CD28-PC5, CD56-
PE/CD16-FITC, and CD3-ECD/CD4-FITC/CD25-RD1.
These mAbs enabled us to identify T cells (CD3+) and
various subpopulations of T cells, including CD4+T cells,
CD8+T cells, naïve T cells (CD4+CD45RA+ T cells),
memory T cells (CD4+CD45RO+ T cells), CD8+CD28+
T cells, B cells, and NK cells (CD56+CD16+).
Proliferative response of T cells
The proliferative response of T cells to anti-CD3 mAb
(Orthoclone OKT3; Ortho Biotec, NJ) was assessed
according to the MTS method (Cell Titer 96 Aqueous
One Solution Cell Proliferation Assay; Promega Co., WI).
Assays were performed in microplates (3860-096, Asahi
Glass Co., Japan). Cells (1 × 105) were grown in 0.2 ml of
RPMI 1640 medium, supplemented with 5% foetal bovine
serum (FBS), and were stimulated with immobilised
anti-CD3 mAb (Orthoclone OKT3; Ortho Biotec). The
plates were then placed in a 5% CO2 incubator for 72
hrs. After incubation for 68 h, 40 μl of MTS solution
(Cell Titer 96 Aqueous One Solution Cell Proliferation
Assay; Promega Co.) was added into each well and the50 - 59 60 - 69 70 – 79 80 Total
37 29 22 3 162
34 18 26 4 194
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metric plate reader; this value was used for determining the
relative magnitude of T cell proliferation.
T cells proliferation index (TCPI)
TCPI was calculated by the following equation:
TCPI ¼ T cell proliferative activity
 T cell number per mm3=1000 
T cell proliferative activity was based on in vitro data
using an adjusted number of lymphocytes and does not
directly reflect the activity at the whole body level. To
convert the T cell proliferative activity to the whole body
level, we devised a new parameter, the T cell proliferation
index (TCPI) [25]. In this equation, T cell proliferative
activity was obtained from the optical density (OD490)
ranging between 0.95 and 2.0 by the above-mentioned
MTS method.
T cell immune score
Five immune parameters related to T cells were selected:
number of T cells, ratio of CD4+ T cells to CD8+ T cells
(CD4/CD8 ratio), number of CD4+CD45RA+ (naïve)
T cells, ratio of CD4+CD45RA+ (naïve) T cells to CD4+
CD45RO+ (memory) T cells (N/M ratio), and TCPI.
The values of immune parameters were standardised
by assigning scores of 3 (high level), 2 (moderate level),
and 1 (low level) according to the database obtained from
300 healthy people. Low, moderate, and high levels were
assigned to values with a cumulative frequency of less
than 10%, 10% to 40%, and more than 40%, respectively.
After standardization, the scores from different types of
immune parameters were summed, and the numerical
value obtained for each individual was termed the T cell
immune score, ranging from 5 to 15.
Cytokine production
The cells (1 × 106) were grown in 0.5 ml of RPMI 1640
medium, supplemented with 10% FBS, and were stimulated
with immobilised anti-CD3 mAb (Orthoclone OKT3;
Ortho Biotec). The plates were then placed in a CO2
incubator, and the supernatant was collected 48 h later.
A flow cytomix kit (BMS810FF; Bender MedSystems,
Austria) was employed for the evaluation of cytokines
(Interleukin (IL)-2, IL-6, IL-10, and interferon (IFN) γ), and
the assessment was performed using a FACScan analyser.
Statistical analysis
The difference in immune parameters or score between
men and women was analysed by the Standardized Major
Axis Test and Routines [26]. In the tables, slope, intercept,
R, and the p value of the regression line are shown, and thep-values of the comparison between men and women
are also shown.
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